期刊文献+

吉西他滨联合顺铂对非小细胞肺癌不同中医证型的疗效及毒副作用的观察 被引量:4

Efficacy and toxicity of gemcitabine combined with cisplatin in the treatment of non-small cell lung cancer with different TCM syndromes
下载PDF
导出
摘要 目的:观察吉西他滨联合顺铂(GP)治疗不同中医证型中晚期非小细胞肺癌的临床症状改善情况、疗效及毒副反应。方法:观察2015年1月至2016年1月我院收治的中晚期非小细胞肺癌患者,按照中医辨证分为气虚证、阴虚证及痰湿证各20例,均给予GP方案化疗。21天为1个周期,治疗4个周期后评价疗效。结果:GP方案在改善咳嗽症状方面,气虚证、阴虚证优于痰湿证,在改善气短症状方面,痰湿证优于气虚证、阴虚证;GP方案在化疗有效率方面,痰湿证高于气虚证、阴虚证;GP方案在化疗毒副反应方面,气虚证、阴虚证较痰湿证重。结论:GP方案对中晚期NSCLC各种中医证型均有一定疗效,其中对痰湿证总体疗效更为显著,毒副反应也相对较小。 Objective: To observe the improvement of clinical symptoms, efficacy and toxicity of gemcitabine combined with cisplatin(GP) in the treatment of advanced non small cell lung cancer with different TCM syndrome types. Methods: from January 2016 to January2015 in our hospital were treated in patients with advanced non-small cell lung cancer patients, according to TCM syndrome differentiation isdivided into qi deficiency, yin deficiency and phlegm dampness syndrome accounted for 20 cases. GP regimen chemotherapy. 21 days for 1 cycles, 4 cycles after treatment evaluation of efficacy. Results: GP regimen in improving cough symptoms, syndrome of deficiency of qi and yindeficiency syndrome is better than that of phlegm dampness syndrome, in improving the symptoms of shortness of breath, phlegm dampnesssyndrome is better than that of qi deficiency, yin deficiency syndrome; GP regimen in chemotherapy efficiency and phlegm dampness syn-drome is higher than that of qi deficiency, yin deficiency syndrome; GP regimen in chemotherapy toxicity aspects, qi deficiency, yin deficien-cy syndrome compared with phlegm wet heavy card. Conclusion: the GP program has a certain effect on the various TCM syndrome types inthe middle and late stage of NSCLC, which has a more significant effect on phlegm dampness syndrome, and the toxic and side effects are rela-tively small.
出处 《甘肃医药》 2016年第11期810-812,共3页 Gansu Medical Journal
基金 甘肃省中医药管理局科研课题(项目编号:GZK-2016-83)
关键词 非小细胞肺癌 GP方案 中医证型 化疗疗效 non-small cell lung cancer GP regimen traditional Chinese medicine curative effect of chemotherapy
  • 相关文献

参考文献3

二级参考文献36

  • 1Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously, treated with platinum-based chemotherapy[J]. J Clin Oncol 2000, 18(10) : 2095-2103.
  • 2Fossella FV, DeVore R, Kerr RN, et al. Randomized Phase Ⅲ trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens[J ]. J Clin Oncol, 2000,18(12) : 2354-2357.
  • 3Gridelli C, Gallo C, DiMaio M, et al. A randomised clinical trial of two docetaxel regimens ( weekly vs 3 week) in the second lineof non-small-cell lung cancer. The DISTAK 01 studay[ J ]. Br J Cancer, 2004, 91 (12) : 1996-2004.
  • 4Schiller J, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. N Engl J Med, 2002, 346(2): 92-98.
  • 5Davies A, Lara PN, Mack PC,et al. Docetaxel in non-small-cell lung cancer: a review [J]. Expert Opin Pharmacother, 2003, 4( 4 ) : 553-565.
  • 6Fossella F, Pereira JR, yon Pawel J, et al. Randomized, multinational, phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer : the TAX 326 study group[J]. J Clin Oncol, 2003, 21(16) : 3016-3024.
  • 7Azzoli CG, Baker S Jr, Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small- cell lung cancer.J Clin Oncol, 2009, 27(36): 6251-6266.
  • 8Bonomi P, Kim K, Fairclough D, et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.J Clin Oncol, 2000, 18(3): 623-631.
  • 9Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med, 2002, 346(2): 92-98.
  • 10Goldstraw P, Ball D, JettJ R, et al. Non-smaIl-ceU lung cancer. Lancet, 2011, 378(9804): 1727-1740.

共引文献73

同被引文献68

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部